TALIGEN THERAPEUTICS, INC. SBIR Phase I Award,
A SBIR Phase I contract was awarded to Taligen Therapeutics for $97,278.0 USD from the U.S. Department of Health & Human Services.
Name
# Contributions
Last Contribution
Find more entities like TALIGEN THERAPEUTICS, INC. SBIR Phase I Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
